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Background: Malaria is still a major global health burden, with more than 3.2 billion people in 91 countries remaining
at risk of the disease. Accurately distinguishing malaria from other diseases, especially uncomplicated malaria (UM) from
non-malarial infections (nMI), remains a challenge. Furthermore, the success of rapid diagnostic tests (RDTs) is
threatened by Pfhrp2/3 deletions and decreased sensitivity at low parasitaemia. Analysis of haematological indices can
be used to support the identification of possible malaria cases for further diagnosis, especially in travellers returning
from endemic areas. As a new application for precision medicine, we aimed to evaluate machine learning (ML)
approaches that can accurately classify nMI, UM, and severe malaria (SM) using haematological parameters.
Methods: We obtained haematological data from 2,207 participants collected in Ghana: nMI (n = 978), SM (n = 526),
and UM (n = 703). Six different ML approaches were tested, to select the best approach. An artificial neural network
(ANN) with three hidden layers was used for multi-classification of UM, SM, and uMI. Binary classifiers were developed
to further identify the parameters that can distinguish UM or SM from nMI. Local interpretable model-agnostic
explanations (LIME) were used to explain the binary classifiers.
Results: The multi-classification model had greater than 85% training and testing accuracy to distinguish clinical
malaria from nMI. To distinguish UM from nMI, our approach identified platelet counts, red blood cell (RBC) counts,
lymphocyte counts, and percentages as the top classifiers of UM with 0.801 test accuracy (AUC = 0.866 and F1 score =
0.747). To distinguish SM from nMI, the classifier had a test accuracy of 0.96 (AUC = 0.983 and F1 score = 0.944) with
mean platelet volume and mean cell volume being the unique classifiers of SM. Random forest was used to confirm
the classifications, and it showed that platelet and RBC counts were the major classifiers of UM, regardless of possible
confounders such as patient age and sampling location.
Conclusion: The study provides proof of concept methods that classify UM and SM from nMI, showing that the ML
approach is a feasible tool for clinical decision support. In the future, ML approaches could be incorporated into clinical
decision-support algorithms for the diagnosis of acute febrile illness and monitoring response to acute SM treatment
particularly in endemic settings.
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In 2018, there were 228 million cases of malaria
worldwide, 93% of which occurred in the African re-
gion [1]. Furthermore, approximately 450,000 deaths
were reported, of which 61% were children under 5
years old [1]. According to WHO 2018 report, over
2.7 billion US dollars were spent towards various con-
trol and elimination efforts to address the global bur-
den of malaria [1]. This includes over 2.74 billion
doses of artemisinin-based combination therapies,
procured in 2017 [1]. Unfortunately, incorrect diagno-
sis leads to incorrect treatment. It can increase the
chances of antimalarial drug resistance, or for false
negative diagnosis, it may result in misdiagnosis of
malaria, inappropriate treatment, and progress to se-
vere disease or death [2–4]. The gold standard for
malaria diagnosis is microscopy, which requires exten-
sive training, but rapid diagnostic tests (RDTs) have
become the frontline diagnostic tools for malaria be-
cause of their ease of use at point-of-care [5].
One drawback of RDTs is the emergence of gene dele-
tions of the target antigen, histidine-rich protein
(Pfhrp2/3) in the parasite genome, which render para-
sites undetectable by the most common RDTs [6]. Other
challenges include insufficient sensitivity to detect low-
level parasitaemia and the number of tests which need
to be performed per positive result in settings with de-
clining or low transmission [2, 6, 7]. Different problems
are faced in non-endemic countries, where imported
malaria must be suspected as a possible cause of fever
before an RDT or microscopy would be performed in
the first place, and failure to identify cases at first con-
tact with health services often results in worse clinical
outcomes [8, 9]. Therefore, improved and complemen-
tary malaria diagnostic techniques are required, which
can overcome some or all of these limitations.
Complete blood counts (CBCs) are the most com-
monly performed laboratory test in most hospitals in
both developing and developed countries. The CBC is
usually relied upon to provide clues for the diagnosis
of patients where advanced methods for detection of
specific diseases are lacking, with a parameter such as
decreased platelet counts often associated with severe
malaria (SM) [10, 11]. In addition, haemoglobin (Hb)
levels are very important for the classification of SM
cases [12]. Indeed, the changes in haematological pa-
rameters during clinical malaria have been studied ex-
tensively to aid in the understanding of disease
pathogenesis [13–19]. However, the potential and
diagnostic value of haematological parameters mea-
sured by commonly available automated haematology
analysers has not been fully studied using unbiased
approaches such as machine learning (ML) tech-
niques. These haematological parameters have thepotential to be used in differentiating clinical malaria
from other febrile illnesses, especially in areas where
the reliability of RDTs is challenged by the high
prevalence of Pfhrp2/3 deletion mutant parasites.
ML approaches use algorithms based on statistical
assumptions and mathematical rules to learn patterns
and produce meaningful classifications based on the
association of each variable with the disease outcome
[20–24]. These classifications can then be applied to
new disease cases to make classifications on the most
probable cause. This classification capability of ML
has not been extensively implemented in the diagno-
sis of clinical malaria. To date, only a single study
has reported the use of ML to diagnose malaria using
clinical history and symptoms captured verbally and
visually [25]. The sample size (n = 376) was very small
to deduce meaningful classifications, and the author
concluded that more work would be needed [25].
Despite this, there have been far reaching studies on
the application of ML in other areas of malaria re-
search [26–30]. The diagnosis of malaria using ML
on clinical datasets has been impaired by the lack of
large data, as well as difficulty in data curation. More-
over, classical modelling is prone to over-fitting or
under-fitting of data [31], but recent approaches such
as imputation, encoding, centering and scaling of vari-
ables, and model optimization [24] enable augmented
use of ML in malaria classification.
We hypothesized that we can classify clinical mal-
aria and non-malarial infections (nMI) with an ML
approach. We first collected and curated data from
2,207 patients including nMI (n = 978), uncomplicated
malaria (UM) (n = 703), and SM (n = 526). We
generated ML models to classify clinical malaria (UM
and SM) from nMI using haematological parameters.Methods
Study population and sample collection
Standards for Reporting Diagnostic Accuracy Studies
(STARD) guidelines [32, 33] were followed in this study.
The current study utilizes unpublished data of 526 pa-
tients from a previous case-control study of SM con-
ducted by the Navrongo Health Research Centre
(NHRC) located in the Kassena-Nankana Districts
(KNDs) in the Upper East Region of Northern Ghana. In
the original study, children with acute febrile symptoms
admitted to the Navrongo War Memorial Hospital
(NWMH), the only referral facility in the KNDs, were
evaluated for inclusion into the study from August to
December 2002 and May 2003 to April 2004. Full details
of the study procedure, inclusion criteria, and demo-
graphic and clinical characteristics of SM cases may be
reviewed in Oduro et al. [34].
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children between 6 and 59 months who had fever (or
history of fever in the past 24 h) and were admitted to
the NWMH, (2) residence in the Navrongo Health and
Demographic Surveillance System area [34], and (3) will-
ingness of parents/caregivers to offer informed consent.
Criteria for SM diagnosis and enrollment into the ori-
ginal study were classified as having SM by the WHO
standard guidelines that include haemoglobin < 5 g/dL
or haematocrit < 15% [34, 35]. Ethical approval for the
SM study was obtained from the NHRC Institutional Re-
view Board (IRB), Noguchi Memorial Institute of Med-
ical Research (NMIMR) IRB, Naval Medical Research
Center IRB, and Ghana Health Service (GHS) Ethics Re-
view Committee (ERC). Informed consent was obtained
and documented, followed by administration of a ques-
tionnaire about the presenting symptoms and clinical ex-
aminations. Participants who did not consent and meet
the study inclusion criteria and those who had reported
taking antimalarial treatment in the past 2 weeks were
excluded from the study, while those who turned out to
be malaria negative by standard microscopy were with-
drawn from the study. All study samples were taken
prior to initiation of treatment except for samples taken
for clinical monitoring during admission or for follow-
up after discharge from the hospital.
The nMI and UM participants were recruited in a
hospital-based cross-sectional study involving two hospi-
tals: Kintampo North-Municipal Hospital, Kintampo,
and Ledzokuku Krowor Municipal Assembly Hospital
(LEKMA), Accra. The inclusion criteria were (1) out-
patient children 1–15 years old, (2) presenting with fever
or history of fever in the past 24 h or axillary
temperature ≥ 38 °C, (3) and (4) signed informed consent
by self (adolescents) and parent/guardian. The exclusion
criterion was participants with known chronic disease or
history of antimalarial drug use in the past 2 weeks. Eth-
ical approval was also obtained from NMIMR-IRB,
GHS-ERC, and Kintampo Health Research Centre
(KHRC) ERC. A case was defined as nMI if the individ-
ual presenting to the hospital was malaria negative by ei-
ther RDTs, Taqman array, or microscopy. Clinical data
such as age, sex, and body temperature and symptoms
such as fever were collected on recruitment.
Sample collection procedure
Venous blood was collected in the ante-cubital fossa.
Tourniquet was not applied beyond 1 min during vene-
section to avoid haemo-concentration, which could give
erroneous results for all parameters measured. Samples
were taken mostly between 8 am and 12 pm to avoid
variations due to individuals’ activity (such as rehydra-
tion and food intake). Samples (5 mL) were taken into
K3 EDTA tubes (BD Vacutainer; Becton Dickinson, NJ,USA). Samples that could not get analysed within 2 h
from the time of collection were stabilized at 2–8 °C to
avoid changes that could occur in some haematological
parameters should the sample be left on the bench for
more than 3 h. Samples were analysed not later than 24
h from the time of sample storage at 2–8 °C. No capil-
lary blood sample was taken during the study as it pre-
sents with subtle variations from venous blood
parameters. CBC analysis was performed using the auto-
mated ABX Micros 60 haematology analyser, which
measures white blood cell parameters, red blood param-
eters, and platelet parameters (Additional file 1: Table
S1). Data were manually cross-referenced twice for ac-
curacy to ensure consistency in sample collection
procedures.
Statistical classifier: median split
Kernel density estimation, which is a non-parametric
technique, was used to estimate the probability density
function of each haematological parameter and kernel
distribution for each parameter between nMI, UM, and
SM and visualized using density plots in R (R version
4.0.2). The median value within each diagnostic group
(nMI, UM, and SM) was computed, and the mean of
any two group medians was used for ‘median split’ to
generate a dichotomous variable for each parameter (low
and high levels representing below and above median,
respectively) [36]. Contingency tables were used to
summarize the relationship between clinical diagnosis
(nMI, UM, and SM), and each dichotomous parameter.
The generalized linear models for predictive analysis
were used to explain the relationship between the clin-
ical diagnosis and the dichotomous parameter. Odds ra-
tios were computed through the exponent of the
regression coefficients (logits) to estimate the strength of
the relationship. Any OR with 95% confidence interval
(CI) that includes a null value (1.0) indicated that the
parameter was not significantly associated with clinical
diagnosis. ANOVA was used to compare the model with
the null model and chi-square test used to compute the
degree of significance. All the analyses were done in R-
software (R version 4.0.2).
Data pre-processing and normalization
A multivariate imputation via chained equations (MICE)
plot was used to visualize the missing observations in
the data. It was difficult to determine whether the miss-
ing values were missing ‘completely at random’ or ‘miss-
ing at random’ or ‘not at random’ to enable selection of
the imputation method. Therefore, the demographic/
clinical data and microscopy results were not imputed
and were not used for modelling. The majority of the
haematological parameters had less than 5% missing
data, and the missing values were imputed using MICE
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was transformed using the Yeo-Johnson function,
centred to have a mean of 0, and scaled to have a stand-
ard deviation of 1. The original dataset (before pre-
processing and normalization) is available in Add-
itional file 2: Table S2.
Machine learning
Six ML algorithms were evaluated to identify the best al-
gorithm that can classify the binary data. These include
partial least squares (PLS) logistic regression, multiple
adaptive regression splines (MARS), random forest, deci-
sion trees, support vector machine, and artificial neural
networks (ANN). PLS logistic regression was imple-
mented by reducing the dimension of haematological pa-
rameters so as to increase accuracy. We used 10-fold
cross-validation while tuning through 16 principal com-
ponents (PC), whereby the optimal model used 2 PC.
The optimal hyperparameters for MARS (with cross-
validation) were determined in a grid search of 30 differ-
ent combinations of 3rd degree and sampling 1000
terms to retain the final model [37]. Decision tree was
implemented with the rpart function, which performs
auto-tuning with an optimal subtree of 10 total tree
splits. Random forest and support vector machines were
implemented by first performing a grid search to identify
the optimal hyperparameters followed by classification
analysis. Three ANN were developed, one multi-
classification ANN (nMI vs UM vs SM) and two binary
classifications denoted as ANN (UM and nMI) and
ANN (SM and nMI). For each ML model, the data were
split into 80% training and 20% testing. The outcome
was the clinical diagnosis of the participant (as con-
cluded by the attending clinicians) having either UM or
nMI or SM. Haemoglobin and haematocrit levels were
not included in the modelling because they are used to
support the diagnosis of malaria [10, 19, 35, 38].
Hyperparameter tuning for artificial neural networks
The ANN was composed of an input layer of 15 haem-
atological parameters. The loss was computed using cat-
egorical cross-entropy for the multi-classifier and binary
cross-entropy for binary classifiers, while accuracy was
used as the main evaluation metric. During training, the
80% training data was further split into 70% training and
30% validation with randomization (Fig. 1). Tensor
board visualizations were used to check the dynamic
graphs of our training and test metrics. Hyperparameters
were tuned to identify the optimal model parameters for
each classification. A hyper-grid was developed that ad-
justs the model capacity, normalization term, kernel
regularization, and learning rate. To maximize the valid-
ation error performance, we tuned 12, 32, 64, 128, 256,
and 512 rectified linear units (ReLU) in three hiddenlayers. We used batch normalization on each hidden
layer for gradient propagation and performance im-
provement. We varied the dropout rate from 0.1, 0.2,
0.3, and 0.4 in all the three layers to identify the best
dropout regularization that prevents the model from
latching to happenstance patterns that are not signifi-
cant. We used ‘Adam’ as the optimizer, but we varied
the learning rate (0.1, 0.05, 0.001, and 0.0001) to find a
global minimum. The tfruns R package was used to im-
plement the hyper-grid in R-software, using 500 epochs,
batch size of 64, and validation split of 0.3. These Keras
models were initialized for all the three classifications to
select the optimal model.
Model evaluations
Yardstick package was used to perform classifications on
the test data as well as compute the performance of the
model. The confusion matrix, accuracy, area under the
receiver operating characteristic curve (AUC), precision
and recall, and F1 score were the metrics used to evalu-
ate performance. The F1 score is a measure of test data
accuracy, which is a weighted average between precision
and recall. To explain the model, we used local inter-
pretable model-agnostic explanations (LIME Package in
R) [39]. The classification model was set up, and an ‘ex-
plainer’ of the classifying model was initiated using the
training data and the model output classifications. The
explainer was used to explain the results of the test data-
set as classification explanations (feature weights). The
feature weights were used to build a heatmap for each
ANN indicating how each feature explains the model.
Effect of patient age and sampling location on the model
predictions
To test if patient age and sampling location significantly
affected the models, we used three models: (1) a model
for all the UM and nMI cases (n = 1681), (2) a model for
UM and nMI from Kintampo cases only (n = 726), and
(3) a model for only Kintampo cases and ages under 4
years (n = 416). We tested the possibility of using the
ANN to evaluate the models but there was some level of
over-fitting and under-fitting of the 2nd and 3rd models,
due to sample size limitation. Therefore, random forest
was subsequently used, because of (1) its robustness to
smaller sample size with minimal over-fitting of the data
and (2) its ability to reduce the high variance from deci-
sion trees by combining several trees into one ensemble
tree [40].
Statistical analysis
The clinical categorical data was analysed using Pear-
son’s chi-square while the continuous data such as the
haematological parameters were analysed using the
Kruskal-Wallis test with Dunn’s post hoc tests across
Fig. 1 Study population and data splitting for building the ANN for clinical malaria. Samples were collected from one low transmission area
(Accra, n = 857) and two high transmission areas: Kintampo (n = 726) and Navrongo (n = 624). The nMI (n = 978) were collected from Kintampo
and Accra and UM (n = 703) were collected from all three areas, while the SM (n = 526) samples were collected from Navrongo. A multi-
classification ANN model was developed for nMI, UM, and SM, which was further evaluated by binary ANN models (1) ANN (UM vs nMI) and (2)
ANN (SM vs nMI). For each model, data splitting was achieved by dividing data in an 80:20% ratio into training (Train) and testing (Test). The 80%
training data was further split into a 70:30% ratio for training (Train) and cross-validation (xVal-set)
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sided, and statistical significance was set at P < 0.05 for
all analyses with adjustment for multiple testing. Data
analyses were performed using R-software (R version
4.0.2), R-studio (version 1.1), and Python (version 2.7).
The R codes with the methods, including the curated
data files, can be found on github: https://github.com/
misita-falcon/Machine-Learning-in-Clinical-Malaria.
Results
Characteristics of the study participants
Participants were recruited as follows: 38.8% (857/2,207)
from Accra, 32.9% (726/2,207) from Kintampo, and
28.3% (624/2,207) from Navrongo (Fig. 1). These partici-
pants from all the three locations constitute 44.3% (978/
2,207) nMI, 31.8% (703/2,207) for UM, and 23.8% (526/
2,207) for SM cases (Fig. 1). The median age was 3 years
(range 2–6 years) for nMI, 4 years (range 2–7 years) for
UM, and 1 year (range 1–2 years) for SM. The median
ages were significantly different as determined by the
Kruskal-Wallis test (P < 0.001) (Table 1). The SM cases
had a significantly higher median body temperature
(38.3; range = 37.5–39.2), compared to the nMI (37.2;
range = 36.5–38.4) and UM (38.1; range = 37–39) (P <0.001). There was a significant difference in proportions
of individuals (P < 0.001) among nMI, UM, and SM from
different locations (Kintampo, Navrongo, and Accra) as
determined by the chi-square analysis (Table 1). There
was no association between sex and clinical diagnosis, al-
though the number of females was higher than males in
all three groups (P = 0.247); nMI was 51.2% (501/978),
UM was 54.9% (386/703), and SM was 55.1% (290/526)
(Table 1). Fever was more common in SM (99.2%, 522/
526) compared to UM (85.5%, 601/703) and lowest in
nMI (59.4%, 581/978), and the chi-square analysis shows
that there was an association between fever and clinical
diagnosis (P < 0.001) (Table 1).
Participants with UM had a higher geometric mean
parasite density (27,467.59 parasites/μL, SD = 8.44) com-
pared to SM individuals (16,674.41 parasites/μL, SD =
8.61). But, the median levels did not vary significantly
between the two groups (P = 0.592) (Table 1). Partici-
pants with nMI were negative by microscopy, RDT, and
Taqman array. There were 212 different suspected infec-
tions in the nMI group, and the top 10 include upper re-
spiratory tract infections (17%, 167/978), malaria (9.5%,
93/978), gastroenteritis (7.6%, 75/978), sepsis (6.1%, 60/
978), otitis media (5.9%, 58/978), enteric fever (2.6%, 26/
Table 1 Characteristics of study participants for nMI, UM, and SM (n = 2,207)
Characteristic Non-malaria infections (nMI) Uncomplicated malaria (UM) Severe malaria (SM)
N = 2,207 N = 978 (44.3%) N = 703 (31.8%) N = 526 (23.8%) P value
Patient age
Mean (SD) 4.23 (3.57) 4.95 (3.57) 1.66 (0.93) < 0.001a
Median (range) 3.0 (2–6) 4.0 (2–7) 1.0 (1–2)
Body temperature
Mean (SD) 37.4 (1.18) 38.1 (1.23) 38.4 (1.15) < 0.001a
Median (range) 37.2 (36.5–38.4) 38.1 (37–39) 38.3 (37.5–39.2)
Parasite density
Geometric mean (SD) 0 0 27,467.59 8.44 16,674.41 8.61 0.592c
Median (range) 0 0 29,426 3,144–105,351 25,160 3,560–86,560
Location
Accra (n, %) 657 (67.2%) 200 (28.4%) 0 (0.0%) < 0.001b
Kintampo (n, %) 321 (32.8%) 405 (57.6%) 0 (0.0%)
Navrongo (n, %) 0.0 (0.0%) 98 (13.9%) 526 (100.0%)
Sex
Female (n, %) 477 (48.8%) 317 (45.1%) 236 (44.9%) 0.209 b
Male (n, %) 501 (51.2%) 386 (54.9%) 290 (55.1%)
Fever symptom
No (n, %) 395 (40.4%) 97 (13.8%) 4 (0.8%) < 0.001 b
Yes (n, %) 581 (59.4%) 601 (85.5%) 522 (99.2%)
Missing (n, %) 2 (0.2%) 5 (0.7%) 0 (0%)
Patient age, body temperature, and parasite density were analysed using the Kruskal-Wallis test while recruitment location, sex, and fever were analysed using the chi-square
test at 95% CI. All the participant characteristics were significantly different between the nMI, UM, and SM except median parasite density and patient sex
aKruskal-Wallis test
bChi-square test
cDunn (1964) Kruskal-Wallis multiple comparison—UM vs SM only
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pneumonia (2.1%, 21/978), and anaemia (1.9%, 19/978)
(Additional file 1: Fig. S1). Laboratory results indicated
that majority of the samples were undetermined/not
available/not known (96%, 937/978), with only 4% hav-
ing accurate laboratory results (41/978). Some of the or-
ganisms that were laboratory confirmed include
Streptococcus pneumonia, Staphylococcus aureus, Sal-
monella typhi, Coxiella burnetii, and dengue virus
(Fig. 2). Only 2 UM participants had co-infections (la-
boratory confirmed) with P. falciparum, and these indi-
viduals had Salmonella typhi and group D streptococcus.
Since the sample size of laboratory-confirmed nMI cases
was low, all the samples were grouped as nMI, instead of
individual diseases during ML classifications.
Haematological parameters vary between nMI, UM, and SM
Median values for all the haematological parameters
were significantly different among nMI, UM, and SM
(P < 0.001) (Table 2), but most of the parameters do not
show distinct distributions between the different clinical
diagnosis groups (Fig. 3). More so, Dunn’s post hoc tests
indicated that platelet distribution width, percentageneutrophils, and percentage lymphocytes were not sig-
nificantly different between the nMI and SM (Table 2).
Similarly, the pairwise comparisons showed that mean
cell volume, neutrophil count, and mean platelet volume
were not significantly different between nMI and UM
(Table 2). Despite the statistical test, we hypothesized
that the median differences for each parameter cannot
be used to confidently classify the disease outcomes.
To further confirm this hypothesis, the median was
used to split the variables into categorical variables (low
and high levels). The relationship or predictive value of
the categorical parameters to accurately classify the clin-
ical diagnosis was determined using contingency tables
(Additional file 2: Table S3). The percentage number of
individuals who had low levels of each parameter and
were classified with nMI ranged from 29 to 70% (UM
group) and 7 to 82% (SM group) (Fig. 4a). Compara-
tively, the percentage of individuals who had low levels
of each parameter and were classified with UM ranged
between 30 and 71%, while the percentage of individuals
who were classified with SM ranged between 17 and
91% (Fig. 4b). There were similar trends for the percent-
age number of individuals who had high levels of each
Fig. 2 (See legend on next page.)
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Fig. 2 Clinical manifestations using laboratory diagnosis compared to various suspected infections by clinicians. Blood, urine, and stool samples
were collected from majority of the individuals who were categorized as nMI. Cultures of either blood, urine, or stool were performed, depending
on the clinician’s request and the suspected illness. The suspected organisms were categorized as either bacteria, viral, fungi, and protozoan or a
combination of bacteria/protozoan, fungi/protozoan, viral/protozoan, and viral/bacteria. Laboratory results confirmed only 4% of the cases with
the majority being undetermined/not available/not known (96%, 937/978). The major organisms determined to be present include dengue virus,
Staphylococcus aureus, Salmonella typhi, Streptococcus pneumonia, and Coxiella burnetii. a shows the absolute counts of each diagnosed organism
coloured by the suspected organisms while b shows the proportion of each diagnosed organism coloured by the suspected organism. HIV
stands for Human immunodeficiency virus, URTI for upper respiratory tract infection, Pf for Plasmodium falciparum and SPP for species
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SM (Fig. 4c, d).
Additionally, we determined whether the levels could
predict whether an individual has UM or SM using odds
ratios. First, we predicted UM, and majority of the param-
eters were associated with clinical diagnosis of UM and
nMI (P < 0.001), except mean cell volume, lymphocyte
percentage, mixed cell counts, and neutrophil counts
(Additional file 1: Table S4). The parameters that were
not associated for nMI–SM category were lymphocyte
counts, mean corpuscular Hb, lymphocyte percentage,
mixed cell counts, and neutrophil counts (Additional file 1:Table 2 Comparison of median and interquartile ranges in haemato
Non-malaria




Parameters Median IQR Median IQR
WBC indices
WBC count (103/μL) 9.3 7.0–12.8 8.3 6.3
Lymphocyte count (103/μL) 3.0 2.0–4.5 1.9 1.3
Mixed cell count (103/μL) 0.8 0.5–1.1 0.5 0.3
Neutrophil count (103/μL) 4.8 3.3–7.6 5.4 3.7
Lymphocyte percent (%) 35.8 22.6–47.8 24.7 16.
Mixed cell percent (%) 8.6 6.7–11.0 6.9 5.0
Neutrophil percent (%) 54.4 41.7–69.0 67.8 53.
RBC indices
RBC count (106/μL) 4.5 4.2–5.0 4.1 3.6
Hb level (g/dL) 11.0 10.1–11.8 10.1 8.8
Haematocrit (%) 34.5 32–37.1 31.1 27.
RBC distribution width (%) 15.1 14.0–16.6 15.7 14.
Mean cell volume (fL) 76.0 71.2–80.3 76.0 72.
Mean corpuscular Hb (pg) 23.7 21.8–25.6 24.9 23.
Mean cell Hb concentration (g/dL) 31.6 29.6–32.5 32.3 31.
Platelet indices
Platelet count (103/μL) 292.0 226.0–360.0 140.0 92.
Mean platelet volume (fL) 8.2 7.6–8.9 8.1 7.5
Platelet distribution width (fL) 15.0 13.9–15.4 14.5 12.
P value—Kruskal-Wallis test with Dunn’s post hoc tests
P values were analysed using the Kruskal-Wallis test with post hoc tests. The param
haematological parameters were significantly different between the nMI, UM, and STable S4). Furthermore, some of the haematological pa-
rameters had a 95% confidence interval that included the
null value (1) when evaluating the odds ratios, which sig-
nifies that they are not significantly associated with clinical
diagnosis (Additional file 1: Table S4).
Machine learning attained over 77.7% accuracy in
classifying clinical malaria from nMI
Since there is no clear distinction between the distribu-
tions and the inability of the median-based categories to
clearly classify the participant’s clinical diagnosis, we
sought to evaluate six ML approaches to classify clinicallogy values measured in nMI, UM, and SM cases
ed
= 703
a vs b Severe malaria (c),
N = 526
b vs c a vs c a vs b vs c
P value Median IQR P value P value P value
–10.8 < 0.001 11.6 8.3–16.6 < 0.001 < 0.001 < 0.001
–3.0 < 0.001 3.8 2.4–6.0 < 0.001 < 0.001 < 0.001
–0.8 < 0.001 0.9 0.5–1.4 < 0.001 0.004 < 0.001
–7.6 0.115 6.5 4.4–9.4 < 0.001 < 0.001 < 0.001
8–36.8 < 0.001 33.9 26.5–44.4 < 0.001 0.964 < 0.001
–9.2 < 0.001 8.2 5.5–11.3 < 0.001 0.012 < 0.001
7–77.1 < 0.001 55.8 46.6–66.2 < 0.001 0.568 < 0.001
–4.5 < 0.001 2.4 1.7–3.2 < 0.001 < 0.001 < 0.001
–11.2 < 0.001 5.6 4.1–7.4 < 0.001 < 0.001 < 0.001
2–34.8 < 0.001 16.7 12.0–21.1 < 0.001 < 0.001 < 0.001
7–17.1 < 0.001 18.1 16.2–20.1 < 0.001 < 0.001 < 0.001
0–81.0 0.510 70.0 64.7–75.4 < 0.001 < 0.001 < 0.001
0–26.4 < 0.001 23.8 21.5–26.7 0.001 0.006 < 0.001
5–33.3 < 0.001 35.1 31.2–37.4 < 0.001 < 0.001 < 0.001
0–216.0 < 0.001 98.0 61.0–156.0 < 0.001 < 0.001 < 0.001
–8.9 0.186 6.9 6.4–7.8 < 0.001 < 0.001 < 0.001
4–15.6 0.005 15 12.0–17.3 < 0.001 0.121 < 0.001
eters include WBC indices, RBC indices, and platelet indices. All the
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Fig. 3 Density estimates of the haematological parameters between nMI, UM, and SM cases. The plots indicate the distribution of each
haematological parameter for each clinical diagnosis category. The plot uses the kernel density estimate that allows for smoother distributions by
smoothing out the noise. The peaks of each density plot are displaying the point where values are concentrated over the interval. Below each
plot is the label of the haematological parameter it is estimating
Morang’a et al. BMC Medicine          (2020) 18:375 Page 9 of 16malaria from nMI. The UM vs nMI model was trained
on 942 samples, validated on 403 samples, and tested on
336 samples for each ML approach. The SM vs nMI
model was trained on 843 samples, validated on 361
samples, and tested on 300 samples for each MLapproach (Fig. 1). Among the six ML approaches, the
training accuracies ranged between 0.794 and 0.856 to
classify UM while the training accuracies ranged be-
tween 0.937 and 0.985 in classifying SM. The test accur-
acies ranged from 0.777 to 0.857 for the UM model and
Fig. 4 Non-symmetrical predictive values of clinical diagnosis using median split (high vs low levels) of each haematological parameter. A
‘median split’ was used to divide each quantitative parameter into categorical variables by the median value (calculated as a mean of nMI and
UM or SM median value shown in Table 2). The predictive values are calculated from contingency tables (Additional file 2: Table S3). a The
percentage predictive value in predicting nMI from low levels. b Percentage predictive value in predicting SM or UM using the low levels. c
Percentage predictive value in predicting nMI using high levels. d Predictive values of UM or SM using high levels
Morang’a et al. BMC Medicine          (2020) 18:375 Page 10 of 160.930 to 0.973 for the SM model (Additional file 1: Table
S5). The SVM approach and the ANN generated the
overall best classification outcome.
Hyperparameter tuning for the ANN (n = 55,290 com-
binations) showed that the optimal model for multi-
classification had 0.862 training accuracy with a model
capacity of 3 layers (128, 64, and 16), with dropouts of
0.4 for layer 1, 0.3 for layer 2, and 0.4 for layer 3, and
learning rate of 0.001 (as represented in Additional file 1:
Fig. S2). The optimal model (n = 55,290 combinations)
for ANN (nMI vs SM) with 0.985 accuracy had a model
capacity of 3 layers (16, 128, and 256 RELU units, re-
spectively), the dropout rate was 0.2 and 0.4 for the first
two layers and the last layer had 0.1, and a learning rate
of 0.0001. The optimal model (n = 55,290 combinations)
for ANN (nMI vs UM) with 0.856 training accuracy had
a model capacity of 3 hidden layers of 256, 64, and 16
RELU units, respectively; the dropout rate was 0.1 forthe first and last layer and 0.3 for the second layer, and a
learning rate of 0.0001. Training and validation history
plots for the ANN showed good levelling off for accur-
acy and loss, as well as acceptable divergence between
training loss/accuracy and validation loss/accuracy for
all the three models (Additional file 1: Fig. S3).
Also, the history plots suggest that there was near zero
over-fitting or under-fitting of the data as indicated by
closeness of the training and validation curves (Add-
itional file 1: Fig. S3). The ANN (UM vs. nMI) achieved
0.856 training accuracy and 0.842 validation accuracy,
while the testing accuracy of the model was 0.801 (kappa
0.583) (Table 3). The training and testing accuracies
demonstrate the confidence of the networks in classify-
ing UM. The ANN (SM vs nMI) achieved a higher ac-
curacy (≥ 0.96) for training, validation, and testing
accuracy (Table 3). Both ANN had an F1 score of above
0.747, which means the model can be used for the
Table 3 Performance of classification models for identifying parameters that can be classified with clinical malaria
ANN UM vs SM vs nMI UM vs nMI SM vs nMI
Model type Multi-classification model Binary model Binary model
Data splitting
Total data (100%) n = 2,207 n = 1,681 n = 1,504
Training and validation data (80%) n = 1,766 n = 1,345 n = 1,204
Testing data (20%) n = 441 n = 336 n = 300
Training performance
Training accuracy 0.862 0.856 0.985
Training loss 0.396 0.425 0.062
Validation accuracy 0.828 0.842 0.978
Validation loss 0.432 0.434 0.102
Testing performance
Testing accuracy 0.853 0.801 0.96
Kappa 0.768 0.583 0.913
ROC_AUC NAa 0.866 0.983
Precision 0.855 0.780 0.971
Recall 0.856 0.717 0.918
F1 score 0.856 0.747 0.944
Training and cross-validation accuracy as well as testing accuracy, area under the ROC curve (AUC), precision, recall, and F1 score. Multiclass analysis among all
three-disease conditions, training accuracy was 0.862 with 0.828 validation accuracy. The model classified the three classes with 0.853 test accuracy. The ANN (UM
vs nMI) had an accuracy of ≥ 0.801 for training, validation, and testing accuracy. The ANN (SM vs nMI) had the highest classification accuracy of ≥ 0.96
aWe did not generate ROC-AUC for multi-classification models
Morang’a et al. BMC Medicine          (2020) 18:375 Page 11 of 16classification of clinical malaria (Table 3). Since the bin-
ary classifiers had the best performance, we also per-
formed a multi-classification analysis to assess the ability
of the ANN to differentiate among UM, SM, and nMI.
The data available for the multi-classification model was
2,207 samples, which were split to 80% training (n =
1,766) and 20% testing (n = 441). The training data was
further split to 70% (n = 1,236) training and 30% (n =
530) cross-validation with accuracies of 0.862 and 0.828,
respectively. The test accuracy was 0.853; kappa, preci-
sion, recall, and F1 score of the model was > 0.768
(Table 3). The accuracy of multi-classification model
provides confidence in the binary classifications.
Diagnostic value of the models using ROC curves
Having shown the accuracy of the models, we deter-
mined the ROC curves of ANN (UM vs nMI) and ANN
(SM vs nMI) to show the diagnostic ability of these bin-
ary classifiers. Both classifiers had very good perform-
ance with an AUC of 0.866 for ANN (UM vs nMI) and
AUC of 0.983 for ANN (SM vs nMI) (Fig. 5 and Table 3).
This showed that the models could be used to distin-
guish individuals with SM or UM from those with nMI.
The cut-offs for UM show that there is a trade-off in
sensitivity and specificity as the cut-off increases or de-
creases, which is not the case for SM. These results
could frame the clinical utility of the models and provide
a benchmark for future studies.Platelet and RBC counts classify clinical malaria from non-
malaria infections
The models were investigated to identify which haem-
atological parameters were classified to be important for
either SM, UM, or nMI using local interpretable model-
agnostic explanations (LIME). Case by case analysis of
the individuals showed that some haematological param-
eters are important classifiers of UM (Additional file 1:
Fig. S4). Case by case analysis was merged into heatmap
to generate a consolidated picture of useful parameters
for classification (Fig. 6). The top three parameters that
had low feature weights for UM are platelet counts, RBC
counts, and lymphocyte percentages (Fig. 6a). Based on
the order of importance, the top three parameters that
were important for SM classification include RBC
counts, platelet counts, and mean platelet volume
(Fig. 6b). This shows that both platelet and RBC counts
are important parameters for clinical malaria while the
lymphocyte percentages were unique for UM. These pa-
rameters might be used to classify clinical malaria cases
from nMI, with a very good diagnostic ability as shown
by the ROC analysis (Fig. 5).
Patient age and sampling location do not affect the
model classifications
We further tested if the models are agnostic to age and
location variance. There was a significant difference in
patient age between nMI and UM (P < 0.001), but there
Fig. 5 ROC curve for classification of SM was near perfect. The ROC curve plots sensitivity versus specificity for all possible cut-offs. Each point on
the curve represents a different cut-off value, which is connected to form a curve. The diagonal line is a reference line for the ROC curve. a ROC
for the ANN (UM vs nMI) with an area under the curve (AUC) of 0.866 which is basically an average of true positive rate across all possible false
positive rates. b ROC for the ANN (SM vs nMI) is right angled which means its near perfect with an AUC of 0.983. The levels of AUC indicate a
good performance of the models in classifying UM and SM
Fig. 6 Platelet and RBC counts identified as classifiers of both UM and SM. The Keras model was explained using local interpretable model-
agnostic explanations (LIME Package in R-software). The explainer results of the test data, which are represented as feature weights, were
extracted from the explainer and used to plot the heatmaps to show a consolidated picture of the importance of each haematological
parameter. The weights that are < − 0.1 indicate that they are low during UM or SM. a The heatmap shows that platelet, RBC, and lymphocyte
percentages/counts can classify UM and b shows the haematological parameters that can classify SM, and they include RBC counts, platelet
counts, mean platelet volume, and mean cell volume
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tampo as well as children under the age of 4 years
(Fig. 7a, c, e; Additional file 1: Fig. S5 & S6). The per-
formance accuracy of the random forest models was
0.806, 0.767, and 0.768 for models 1, 2, and 3, respect-
ively (Fig. 7b, d, f). The most important parameters that
were featured across the three models were platelet and
RBC counts, which are similar to the top two parameters
identified by the ANN. Therefore, the data illustrates
that age and location do not affect model classifications,
and the platelet or RBC counts determined by ANN can
be used to reliably classify clinical malaria from nMI in
these datasets.
Discussion
Automated CBC is one of the blood tests routinely per-
formed for children presenting to health facilities with
fever. However, CBC analysis generates a significant
amount of data on a range of haematological parameters,
and the data is underutilized with only Hb and Hct
levels being routinely used as an indicator of clinical
malaria. Thus, an automated algorithm to detect malaria
based on the haematological parameters as outlined inA
B
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Fig. 7 Classification of haematological parameters using random forest sho
models. Three models were generated: a a model for all the UM and nMI c
while b shows the impurity-based measurement of the feature importance
(n = 756), which do not show any significant difference between the patien
model for only Kintampo cases and ages under 4 years, whereby there was
shows the feature importance of the model. The samples for each model w
models was 0.806, 0.767, and 0.768, respectively. The most important featuthis study could have great value as a complementary
malaria diagnostic strategy, particularly at frontline
health centres where CBC is routinely performed. Such
an algorithm also has the added value of enabling the
monitoring of treatment outcomes for in-patients.
In malaria-endemic settings, malaria rapid diagnostic
tests (mRDTs) have revolutionized diagnosis and signifi-
cantly reduced presumptive treatment, particularly in
rural settings where trained microscopists are lacking
[3]. However, reports of emerging Pfhrp2/3 gene dele-
tions threaten the future reliability of the RDTs. False
negative RDT results are also known to occur in low-
density infections [2, 6, 7]. Thus, an approach that is au-
tomated and agnostic to parasite genetic variation is crit-
ical both as a fail-safe and a surveillance strategy for
false negative mRDTs (which might occur due to supply
chain mismanagement or gene variation) [6]. In very
low transmission settings, ML models have the poten-
tial to replace the primary use of mRDTs when the
diagnostic yield of mRDTs becomes very low (i.e.
many mRDTs needed to detect a single case of mal-
aria). In non-endemic settings where malaria may
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ases (n = 1681), which show a significant difference in patient age,
of the model; c a model for UM and nMI from Kintampo cases only
t age, and d shows the feature importance of the model; and e a
no significant difference between the nMI and UM (n = 416) and f
ere split 80% for training and 20% for testing. The accuracy of the
re across the three models was platelet and RBC counts
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the diagnosis of malaria was not suspected by clini-
cians and malaria RDT or microscopy was not per-
formed. Despite these advantages, there would be a
little extra cost associated with incorporating the al-
gorithm and an automated message into haematology
analyser output, a message that can prompt clinicians
to consider malaria in the presence of suggestive
haematological features.
Previous ML studies have looked into haemato-
logical parameters more generally and to classify
sickle cell anaemia using deep convolutional networks
[41, 42], but did not classify clinical diagnosis. For
the first time, ML approaches that can classify infec-
tions in children based on haematological parameters
have been generated. Six different ML methods were
evaluated, and they were all shown to classify clinical
malaria from nMI with high accuracy especially the
SVM and the ANN. We used the ANN to deconvo-
lute the results: it identified platelet and RBC counts
as the top features in classifying both UM or SM
from nMI. Low RBC counts can be attributed to ex-
tensively parasitized RBCs, which are sequestered dur-
ing SM [43]. This highlights the significance of RBC
counts during Plasmodium falciparum malaria infec-
tions. In most occasions except cerebral malaria, SM
is associated with anaemia due to RBC lysis during
parasite invasion as well as many other RBC abnor-
malities [44]. This makes the diagnosis of SM much
easier than UM, whereby one parameter, such as Hb
level of < 5 g/dL, can diagnose or classify the disease.
Cohen et al. analysed data from 680,964 individuals
with fever and confirmed that majority of antimalarial
drugs are given to malaria-negative individuals [45].
Overtreatment indicates that most nMI can go with-
out being treated, for their true cause, which is also
possible for UM and this can lead to drug resistance.
Therefore, the difference between febrile outpatient
infections is far more challenging, especially between
nMI and UM due to similarity in clinical presenta-
tions. In large population studies, values of studied
metrics can be significant but they do not necessarily
distinguish the populations as either nMI or UM as
observed in this study. But, using the ML approach
shown here, distinguishing the nMI and UM can be
improved by combining all haematological parameters
and learning the data-patterns before making classifi-
cations. The predictions made by ML are more accur-
ate and reliable and can be improved by analysing
more datasets. Lymphocyte counts/percentage were
identified to be affected during UM and can be used
to distinguish UM from nMI, mainly because individ-
uals with malaria generally have a distinct immune
response compared to nMI individuals [27, 46, 47].Previous work in our laboratory showed differences in
haematological presentation among areas of varying
transmission intensity in Ghana [48]. To show that dif-
ferences in age and transmission zones (sampling loca-
tion) are not driving our diagnostic classifications, we
down-sampled the data and used random forest to per-
form the classifications. The results showed that platelet
and RBC counts were the key features in classifying UM
and nMI regardless of age and sampling location of the
participants. There were differences in the top three im-
portant features between the random forest and ANN,
but this could be due to the differences in the approach
of each algorithm [23, 49]. This illustrates that patient
age and location do not substantially influence the diag-
nostic classifications in this study. The ROC curves fur-
ther showed that the models could be used for diagnosis
with very reliable AUC values.
There are limitations to be considered in the use of
this ML approach in routine diagnosis and the
generalization of our approach. First, the models can
distinguish between nMI and clinical malaria, but
whether they can be used to distinguish the clinical
disease state will depend on the pre-test probability
or prevalence of malaria in different endemic settings.
Second, all study subjects being Ghanaian children
may limit the generalizability of the models to other
countries; this is also the case for the limited range
of SM manifestations in our dataset and the spectrum
of laboratory-confirmed nMI. The few nMI cases that
were clearly diagnosed and still grouped/retained as
nMI may also present minimal bias to the models.
Lastly, the study did not have adults > 15 years to
comparatively understand the role of age in differenti-
ating clinical malaria based on haematological param-
eters. Therefore, we recommend that more studies
are needed to inform the broader utility of this work.
Despite that only 4.6% (75/1645) of the cases were
discordant between microscopy and RDT, probably
due to hrp2/hrp3 deletions, although there is an in-
significant chance that misclassification of malaria
could have had an impact on our study. These limita-
tions will be taken into account for further studies to
inform the broader clinical utility of this work.
Conclusions
Fever is the most common symptom reported in sSA,
and correct diagnosis of the implicated pathogen is of
high importance for precision medicine. Personalized
treatment reduces overtreatment, decreases malaria
mortality and antimalarial resistance. This report
demonstrates proof-of-principle that ML can be used
to distinguish clinical malaria from nMI using routine
haematological data. Case by case analysis showed
that the models can make classifications based on
Morang’a et al. BMC Medicine          (2020) 18:375 Page 15 of 16combination of three parameters: platelet and RBC
counts, lymphocyte counts/percentage, and mean
platelet volume. These could be used for precision
diagnosis of an individual’s risk of having malaria, to
inform the need for confirmatory diagnosis by mi-
croscopy or to prompt investigation for other diagno-
ses when malaria is unlikely. Further work is to
calibrate and improve the classification capability of
the model using more data from other geographical
and transmission settings, demographic groups, co-
infections, and different disease severities. Our find-
ings hold promise for the design of clinical software
to support the diagnosis of malaria in the WHO Afri-
can region and might also prove useful for the diag-
nosis of malaria in returning travellers from non-
endemic countries.
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